Jun. 25 at 2:23 PM
$EVGN Dear Mr. Haviv,
I hope this letter finds you well. I am writing to express my concerns regarding your continued leadership at Evogene. As a publicly traded company with a market capitalization under
$10 million, it is imperative that we have a leader who instills confidence and trust among stakeholders.Your tenure of nearly 20 years has seen various challenges and changes within the industry, yet many shareholders, including myself, feel that the company has not progressed as it should. The perception is growing that your management has failed to deliver the results we expect, and there is a palpable sense of frustration among investors regarding your ability to lead effectively.It is particularly concerning that the board of directors has not taken action to reassess your position given the current state of the company. The expectation for leadership in a public company differs significantly from that in a scientific association; our focus...
https://www.linkedin.com/posts/evogene_drugdiscovery-pharmainnovation-aginnovation-activity-7338163763486900229-yx2v